SCHEMBL15214873

SCHEMBL15214873

Cc1ccc(-n2ncc3c(NC(C)C)ncnc32)cc1

nearest known ligand 0.79

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 13/20 0.79
NPC1 O15118 5/20 0.79
RAB9A P51151 5/20 0.79
HSD17B10 Q99714 5/20 0.79
SMN1; SMN2 Q16637 4/20 0.79
KDM4E B2RXH2 4/20 0.79
HPGD P15428 3/20 0.79
HTT P42858 2/20 0.79
MEN1 O00255 1/20 0.79
KMT2A Q03164 1/20 0.79
TDP1 Q9NUW8 1/20 0.79
LMNA P02545 8/20 0.78
ALDH1A1 P00352 3/20 0.78
TSHR P16473 2/20 0.78
MAPT P10636 4/20 0.75
PIP4K2A P48426 1/20 0.70
ALPL P05186 1/20 0.62
XDH P47989 1/20 0.60
POLB P06746 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2496169 0.88 TP53 (0.77) TP53NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL10176260 0.88 TP53 (0.81) TP53NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL10360610 0.86 NPC1 (0.73) TP53NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL10226093 0.86 TP53 (0.73) TP53NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL8344591 0.83 LMNA (0.74) TP53NPC1RAB9AHSD17B10KDM4E
SCHEMBL6269930 0.76 XDH (0.68) TP53NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL19700808 0.75 KDM4E (0.62) TP53NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL16156888 0.74 MAPT (1.00) TP53NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL15214856 0.74 KDM4E (0.81) TP53NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL16797492 0.73 MAPT (0.82) TP53NPC1RAB9AHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376085-B1 COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2014-02-26 EP disclosed
US-8518970-B2 Compounds and methods of use ABBVIE INC. (US) 2013-08-27 US disclosed